Stable Istotope Labelled Ozanezumab Biosimilar – Anti-RTN4/NOGO mAb – Research Grade

Reference: PX-TA1313-SIL-1MG
Product nameStable Istotope Labelled Ozanezumab Biosimilar - Anti-RTN4/NOGO mAb - Research Grade
SourceCAS 1310680-64-8
SpeciesHumanized
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsGSK-1223249
ReferencePX-TA1313-SIL
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-nd
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

General information on Anti-RTN4/NOGO[Homo sapiens] (Ozanezumab) Monoclonal Antibody

Ozanezumab has been investigated for the treatment of Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis, Relapsing-Remitting.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Istotope Labelled Ozanezumab Biosimilar – Anti-RTN4/NOGO mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below